Cancer survivors’ self-efficacy to self-manage in the year following primary treatment

Foster, C.; Breckons, M.; Cotterell, P.; Barbosa, Denize Araújo; Calman, L.; Corner, J.; Fenlon, D.; Foster, R.; Grimmett, C.; Richardson, A.; Smith, P. W.

Cancer survivors’ self-efficacy to self-manage in the year following primary treatment

Página do item simplificado Estatísticas

dc.contributor.author	Foster, C.
dc.contributor.author	Breckons, M.
dc.contributor.author	Cotterell, P.
dc.contributor.author	Barbosa, Denize Araújo
dc.contributor.author	Calman, L.
dc.contributor.author	Corner, J.
dc.contributor.author	Fenlon, D.
dc.contributor.author	Foster, R.
dc.contributor.author	Grimmett, C.
dc.contributor.author	Richardson, A.
dc.contributor.author	Smith, P. W.
dc.date.accessioned	2020-04-07T19:27:19Z
dc.date.available	2020-04-07T19:27:19Z
dc.date.issued	2014-07
dc.description.resumo	Purpose Cancer survivors are increasingly expected to manage the consequences of cancer and its treatment for themselves. There is evidence that self-efficacy is important for successful self-management and that this can be enhanced with support. The purpose of this study was to assess self-efficacy to manage problems in the year following primary treatment. Methods This cross-sectional online survey included cancer survivors who had completed their treatment within the past 12 months. Self-efficacy was assessed and variables expected to be associated with self-efficacy were measured using validated scales including quality of life, well-being, illness perceptions, depression and social support. Results One hundred eighty-two respondents (mean age 50; 81 % female) completed the survey. They had been treated for a range of cancers; most commonly breast (45 %). Selfefficacy scores varied between individuals and according to the illness-related task to be managed. Respondents were least confident in managingfatigue and most confident inaccessing information about their cancer. Individuals most likely to report low self-efficacy were women, those experiencing higher levels of pain and/or depression, lower well-being scores, lower socio-economic status, low levels of social support, or a more negative perception of cancer. Conclusions Self-efficacy to self-manage problems faced as a consequence of cancer and its treatment can vary widely in the year following treatment. Fatigue may be particularly difficult to manage. Implications for Cancer Survivors Variations in self-efficacy highlight the importance of assessing specific problems faced and people’s confidence to manage them in order to tailor appropriate self-management support.	pt_BR
dc.identifier.citation	FOSTER, C. et al. Cancer survivors' self-efficacy to self-manage in the year following primary treatment. J Cancer Surviv , v. 9, n.1, p. 11-19, 2015. Disponível em: <https://link.springer.com/article/10.1007%2Fs11764-014-0384-0>. Acesso em: 18 dez. 2017. ISSN 1932-2267 versão online. DOI 10.1007/s11764-014-0384-0. Disponível em: https://link.springer.com/article/10.1007%2Fs11764-014-0384-0#auth-4. Acesso em: 07 abr. 2020.	pt_BR
dc.identifier.doi	10.1007/s11764-014-0384-0
dc.identifier.issn	1932-2259 (print), 1932-2267 (online)
dc.identifier.uri	https://repositorio.ufrn.br/jspui/handle/123456789/28772
dc.language	pt_BR	pt_BR
dc.publisher	Springer	pt_BR
dc.rights	Acesso Aberto	pt_BR
dc.subject	Self-management	pt_BR
dc.subject	Cancer survivors	pt_BR
dc.subject	Self-efficacy	pt_BR
dc.subject	Confidence	pt_BR
dc.subject	Neoplasms	pt_BR
dc.title	Cancer survivors’ self-efficacy to self-manage in the year following primary treatment	pt_BR
dc.type	article	pt_BR